Lv3
328 积分 2024-04-27 加入
Rethinking bronchiectasis as an inflammatory disease
4个月前
已完结
The harms of ultra-processed foods
4个月前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
4个月前
已完结
Bronchiectasis — A Clinical Review
4个月前
已完结
Immune Checkpoint Inhibitors in Geriatric Oncology
4个月前
已完结
Toxicity of Cancer Immunotherapies in Older Patients: Does Age Make a Difference?
4个月前
已完结
The Risk Factors Associated with Immune Checkpoint Inhibitor-Related Pneumonitis
4个月前
已完结
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
4个月前
已完结
Age-related efficacy of immunotherapies in advanced non-small cell lung cancer: a comprehensive meta-analysis
4个月前
已完结
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
4个月前
已完结
皖公网安备34019202002308
